In 2019 Prof Andrew Tobin published validation of PfCLK3 as a target with breakthrough potential in the treatment of malaria. Successful drug development would provide a single medicine that is curative, transmission blocking and prophylactic.
Company Details
- Employees
- 10
- Founded
- -
- Address
- 27 Pembroke Street Upper, Dublin,ireland
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://www.Keltic-pharma.com
- HQ
- Dublin
Keltic Pharma Therapeutics Questions
Keltic Pharma Therapeutics's website is http://www.Keltic-pharma.com
Keltic Pharma Therapeutics's LinkedIn profile is https://ie.linkedin.com/company/keltic-pharma-therapeutics
Keltic Pharma Therapeutics has
10 employees.
View email and phone details for 10
employees at Keltic Pharma Therapeutics.
Keltic Pharma Therapeutics's industry is
Pharmaceutical Manufacturing
Keltic Pharma Therapeutics's top competitors are
Glen Clova Scientific,
Argonaut Therapeutics,
Pharma Integrity,
Cellular Pharmacology - Sygnature Discovery,
Solasta® Bio,
Ilc Therapeutics,
Carrick Therapeutics,
Tay Therapeutics Ltd,
Revona Bio,
Bioascent.
Keltic Pharma Therapeutics's categories are Pharmaceutical Manufacturing
Keltic Pharma Therapeutics's founding year is 2020
